证券代码：301101 证券简称：明月镜片 公告编号：2023-035 截至 2022 年末，立信拥有合伙人 267 名、注册会计师 2,392 名、从业人员 总数 10,620 名，签署过证券服务业务审计报告的注册会计师人数 674 名。 立信 2022 年业务收入（经审计）46.14 亿元，其中审计业务收入 34.08 亿 元，证券业务收入 15.16 亿元。 2022 年度立信为 646 家上市公司提供年报审计服务，审计收费 8.17 亿元， 同行业上市公司审计客户 24 家。 明月镜片股份有限公司 关于聘任公司 2023 年年度会计师事务所的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 明月镜片股份有限公司（以下简称"公司"）于 2023 年 10 月 23 日召开了第 二届董事会第七次会议，审议通过了《关于聘任公司 2023 年年度会计师事务所 的议案》，董事会同意继续聘请立信会计师事务所（特殊普通合伙）（以下简称"立 信"）为公司 2023 年度审计机构。本议案尚需提交公司 2023 年第二次临时股东 大会审议，自股东大会审议通过之日起生效 ...

明月镜片股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------|-----------------------|------------------------------------------------------------------------------------------------------------------------------| | 投资者关系 | √特定对象调研 | | | 活动类别 | □媒体采访 □业绩说明会 | | | | □新闻发布会 | | | | □现场参观 | | | | □其他 | | | 参与单位 | 中金公司、 | Allianz Global Investors Luxembourg S.A、Alpines | | | | 、FIL HKCHAPLT、Goldman Sachs Asset Management International、JM GREAT | | | | CHINA FUND、Matthews International Capital Management,LLC、 | | | | ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥365,939,936.15, representing a 27.78% increase compared to ¥286,390,640.49 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥80,121,334.97, up 53.38% from ¥52,236,561.21 in the previous year[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥70,481,826.51, an increase of 81.56% compared to ¥38,819,244.58 in the same period last year[22]. - The net cash flow from operating activities was ¥94,584,559.32, reflecting a 55.17% increase from ¥60,956,040.83 in the previous year[22]. - Basic earnings per share rose to ¥0.3976, a 53.40% increase from ¥0.2592 in the same period last year[22]. - The company's total profit for the first half of 2023 was CNY 100.06 million, a 47.2% increase from CNY 67.97 million in the same period last year[178]. - The total comprehensive income for the first half of 2023 was 80.1 million, representing a 6.79% increase compared to the previous period[186]. - The company reported a significant increase in retained earnings, with a balance of 201,510,000 at the end of the period[193]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,702,413,138.81, a 2.58% increase from ¥1,659,522,369.65 at the end of the previous year[22]. - The total liabilities increased slightly to ¥148,625,002.62 from ¥147,620,954.99, showing a marginal rise of 0.7%[168]. - Cash and cash equivalents decreased significantly from ¥915,192,342.31 at the beginning of the year to ¥476,725,029.31, a decline of 47.9%[170]. - The total liabilities at the end of the reporting period were 550,230,000, showing effective management of financial obligations[193]. Research and Development - Research and development expenses rose by 26.92% to ¥11.26 million, compared to ¥8.87 million in the same period last year[61]. - The R&D expenditure for the first half of 2023 was 28.7 million, accounting for 5.11% of total revenue[186]. - The company has established partnerships with top research institutions to drive technological advancements, focusing on myopia prevention and functional optical lenses[48]. - As of June 30, 2023, the company holds 161 patents, including 25 invention patents, demonstrating its commitment to innovation and technology[49]. Market Strategy and Expansion - The company aims to become the leading brand in the Chinese lens market, focusing on brand promotion and channel expansion[35]. - The company plans to expand its presence in the medical channel, having completed the establishment of a dedicated team in 2022[35]. - The company is actively expanding its online presence with flagship stores on platforms like Tmall and JD, integrating online and offline sales channels[56]. - The company plans to enhance its mid-to-high-end product line capacity through fundraising projects, although there are risks of not achieving expected returns[89]. - The company plans to expand its market presence and invest in new product development, aiming for a 20% increase in market share by the end of 2024[186]. Environmental Responsibility - The company invested a total of ¥1,223,080.76 in environmental governance and protection during the reporting period[107]. - The company emphasizes a "high efficiency, low energy consumption" green production model to support national carbon reduction goals[108]. - The company has implemented a self-monitoring plan for pollutants, with results showing no exceedances of standards[103]. - The company has committed to reducing carbon emissions through energy management and resource conservation initiatives[108]. Shareholder and Dividend Information - The company plans to increase its dividend payout ratio to 20% in the upcoming fiscal year, enhancing shareholder returns[186]. - The company distributed cash dividends of RMB 3.00 per 10 shares and issued 5 bonus shares, totaling cash dividends of RMB 40,302,420 on May 23, 2023[110]. - The company has implemented a profit distribution policy to enhance shareholder returns and maintain good communication with investors[110]. Corporate Governance - The company has a robust internal control system to protect shareholder rights and ensure accurate information disclosure[109]. - The company has not experienced any significant litigation or arbitration matters during the reporting period[122]. - The company has not engaged in any asset or equity acquisition or sale transactions during the reporting period[125]. Product Development - The company launched the "Easy Control" series of myopia management lenses, which received professional recognition and increased sales confidence among customers[112]. - The company has launched a total of 18 SKUs in the myopia management lens category, maintaining a significant lead in product line richness[51]. - The "Light Control" series products amounted to CNY 54.81 million, showing a significant year-on-year growth of 76%[36]. Customer Engagement - As of June 30, 2023, the company had 2,504 direct sales customers and 46 distribution customers, with direct sales channel revenue of 224.68 million yuan, accounting for 61.40% of total revenue[43]. - The company has established a stable channel structure with tens of thousands of offline terminal stores, enhancing customer engagement through product tasting events and customer salons[54].

明月镜片股份有限公司 投资者关系活动记录表 编号：2023-002 | | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 业绩说明会 | | 投资者关系活动类别 | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 参与单位 | 投资者网上提问 | | 时间 | 2023年5月25日 | | 地点 | 价值在线（https://www.ir-online.cn/）网络互动 | | | 董事长谢公晚 | | 上市公司接待人员姓名 | 董事会秘书兼副总经理曾哲 | | | 独立董事张银杰 | | | 财务总监尉静妮 | | | 1 .公司未来对智能眼镜有没有规划？ | | | 答:公司目前在小米有品旗舰店售卖的智能眼镜sasky具有语音 | | | 助手功能，可以语音唤醒SIRI、小艺、小爱同学，并具有接打电 | | | 话、导航等功能。公司在立足主营业务的同时积极关注布局眼视光 | | | 行业前瞻性技术。 | | | 2 .请问公司是否有在多家医院做轻松控防控效果临床的计划？ | | | 感谢！ | | | 答:202 ...

证券代码：301101 证券简称：明月镜片 公告编号：2023-024 明月镜片股份有限公司 关于举办 2022 年度网上业绩说明会的公告 会议召开方式：网络互动方式 二、参加人员 董事长谢公晚先生、董事会秘书兼副总经理曾哲先生、独立董事张银杰女 士、财务总监尉静妮女士。 会议召开地点：价值在线（www.ir-online.cn） 一、说明会召开的时间、地点和方式 会议召开时间：2023 年 5 月 25 日（星期四）15:00-17:00 会议召开时间：2023 年 5 月 25 日（星期四）15:00-17:00 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会 议 问 题 征 集 ： 投 资 者 可 于 2023 年 5 月 25 日 前 访 问 网 址 https://eseb.cn/14JeIetaQyQ 或使用微信扫描下方小程序码进行会前 提问，公司将通过本次业绩说明会，在信息披露允许范围内就投资者普 遍关注的问题进行回答。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 重要内容提示： 明月镜片股份有限公 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥171,613,712, representing a 26% increase compared to ¥136,199,535.62 in the same period last year[4] - Net profit attributable to shareholders for Q1 2023 was ¥35,050,749.84, a 58.5% increase from ¥22,113,773.37 year-on-year[4] - Basic earnings per share for Q1 2023 were ¥0.2609, reflecting a 58.51% increase compared to ¥0.1646 in the same period last year[4] - Operating profit for the quarter was ¥43,335,541.06, representing a growth of 50.5% from ¥28,804,339.42 in Q1 2022[24] - The total comprehensive income for the period was ¥37,909,230.85, compared to ¥24,309,914.27 in the same quarter last year[24] Cash Flow and Assets - The net cash flow from operating activities reached ¥31,429,846.37, up 234.81% from ¥9,387,448.32 in the previous year[4] - The cash and cash equivalents decreased by 50.20% to ¥465,092,522.18, primarily due to investments in financial products[10] - The net cash flow from investing activities was negative at ¥498,963,185.24, a 37.49% improvement compared to the previous year, reflecting reduced investment in structured deposits[13] - The net cash flow from financing activities was -1,232,325.04 CNY, resulting in a total cash outflow of 16,684,386.56 CNY[27] - The ending balance of cash and cash equivalents was 465,092,522.18 CNY, down from 934,006,089.92 CNY at the beginning of the period[27] Assets and Liabilities - Total assets at the end of Q1 2023 amounted to ¥1,699,705,694.73, a 2.42% increase from ¥1,659,522,369.65 at the end of the previous year[4] - The total current liabilities increased slightly to CNY 140.04 million from CNY 136.23 million at the beginning of the year[21] - The company's non-current liabilities decreased to CNY 9.85 million from CNY 11.39 million at the beginning of the year[21] - The total equity remained stable at CNY 1,036.83 million[21] Sales and Market Performance - In Q1 2023, the sales of the "Easy Control" series products reached CNY 27.57 million, representing a year-on-year growth of 80%[18] - The company reported a strong recovery in offline consumption starting from February 2023, indicating a positive market outlook[18] - The company is focusing on expanding its market presence and enhancing product offerings in response to growing demand[18] Expenses and Investments - The company reported a significant increase in sales expenses, which rose by 32.88% to ¥33,076,283.58, due to higher advertising expenditures[12] - Research and development expenses rose to ¥5,325,996.18, up from ¥4,135,120.23 in the previous year, indicating a focus on innovation[23] Other Financial Metrics - The company's weighted average return on equity was 2.36%, up from 1.56% in the same period last year, indicating improved profitability[4] - Trade receivables increased by 30.95% to ¥148,259,308.49, attributed to higher sales and increased accounts receivable[10] - The inventory decreased to CNY 81.07 million from CNY 89.73 million at the beginning of the year[20] - The accounts receivable rose to CNY 148.26 million from CNY 113.22 million at the beginning of the year[20] - The company did not undergo an audit for the first quarter report[28]

Financial Performance - The company's operating revenue for 2022 was ¥623,065,041.29, representing an increase of 8.25% compared to ¥575,569,283.16 in 2021[18]. - Net profit attributable to shareholders for 2022 was ¥136,185,210.67, a significant increase of 65.89% from ¥82,094,094.80 in 2021[18]. - The basic earnings per share for 2022 was ¥1.0137, up 24.41% from ¥0.8148 in 2021[18]. - The total assets at the end of 2022 amounted to ¥1,659,522,369.65, reflecting a growth of 4.02% from ¥1,595,387,682.94 at the end of 2021[18]. - The company's total revenue for 2022 was CNY 623.07 million, an increase of 8.25% compared to the previous year[53]. - Revenue from lens business reached CNY 477.80 million, up 5.63% year-on-year, while raw material revenue surged by 44.93% to CNY 89.15 million[55]. - The company's gross profit margin for lens products was 60.04%, reflecting a year-on-year increase of 2.97%[56]. - The company reported a net profit margin of 18% for 2022, reflecting improved operational efficiency and cost management[182]. Dividend and Capital Management - The company plans to distribute a cash dividend of 3.00 RMB per 10 shares to all shareholders based on a total share capital of 134,341,400 shares as of December 31, 2022[4]. - The company will increase its capital reserve by converting 5 shares for every 10 shares held by shareholders[4]. - The company distributed a cash dividend of 5.30 RMB per 10 shares, totaling 71,200,942 RMB (including tax) to shareholders based on a total share capital of 134,341,400 shares[152]. - The company plans to distribute a cash dividend of RMB 3.00 per 10 shares, totaling RMB 40,302,420, which represents 100% of the profit distribution amount[153]. - The total share capital after the capital reserve conversion will increase to 201,512,100 shares, with 67,170,700 shares being converted from capital reserves[153]. Research and Development - The company has a total of 152 patents as of December 31, 2022, including 21 invention patents, 110 utility model patents, and 21 design patents[46]. - The company has invested in brand building, enhancing its market influence through advertising and partnerships with popular media programs[42]. - The company will increase R&D investment and collaborate with renowned universities to enhance its technological capabilities, including establishing research centers with Shanghai University of Technology and Nanjing University of Technology[99]. - Research and development expenses increased by 25.21% to ¥22,369,466.61, reflecting the company's increased investment in R&D[64]. - Investment in R&D has increased by 15%, focusing on innovative technologies to maintain competitive advantage[184]. Market Position and Strategy - The company maintained a market share of 10.7% in the Chinese lens market, ranking first according to Euromonitor data[27]. - The company aims to become the leading brand in the Chinese lens market, withdrawing from price wars and focusing on brand development and channel expansion[34]. - The company plans to enhance the promotion of its "Easy Control" series products and expand its market presence in 2023[96]. - The company aims to increase its operational bases from one to four, expanding into Guangdong, Zhejiang, and Anhui provinces in addition to Jiangsu[97]. - The company is exploring potential mergers and acquisitions to strengthen its competitive position, with a budget of 500 million yuan allocated for this purpose[181]. Governance and Compliance - The board of directors has confirmed the accuracy and completeness of the annual report, ensuring no misleading statements or omissions[4]. - The company maintains complete independence from its controlling shareholders in terms of assets, personnel, finance, and operations[120]. - The company has a transparent and fair performance evaluation and incentive mechanism for senior management[115]. - The company has established specialized committees within the board, including a remuneration and assessment committee[115]. - The company has maintained compliance with relevant laws and regulations, ensuring the protection of shareholders' rights[144]. Environmental Responsibility - The company invested a total of ¥2,783,554.98 in environmental governance and protection during the reporting period[168]. - The company has established a third-party cooperation for the detection of wastewater and air pollutants, ensuring compliance with environmental regulations[168]. - The company adopted energy management practices to reduce carbon emissions, including the use of RO wastewater for cleaning purposes[169]. - The company has committed to a "high efficiency, low energy consumption" green production model to support national carbon reduction goals[169]. - The company has no reported administrative penalties related to environmental issues during the reporting period[170]. Employee Management - The total number of employees at the end of the reporting period was 962, including 863 at the parent company and 99 at major subsidiaries[148]. - The company has implemented a competitive and fair salary system, linking salary packages to business performance and development results[150]. - The company has introduced a diversified incentive mechanism to enhance employee motivation and align efforts with business objectives[150]. - The training program covers all levels and positions, enhancing employee skills through both online and offline training methods[151]. - The company has established lean management projects to improve operational efficiency and employee skills[151]. Future Outlook - The company provided a positive outlook for 2023, projecting a revenue growth of 10% to 12% based on market expansion strategies[181]. - New product launches are expected to contribute an additional 200 million yuan in revenue in 2023, focusing on innovative lens technologies[182]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the next two years[181]. - Future guidance includes a target of 1.8 billion CNY in revenue for 2023, with a focus on maintaining a sustainable growth trajectory[185]. - The company aims to reduce operational costs by 10% through efficiency improvements and process optimization[183].

明月镜片股份有限公司 投资者关系活动记录表 编号：2022-001 | --- | --- | --- | |------------------------------|------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

明月镜片股份有限公司 投资者关系活动记录表 编号：2022-003 投资者关系 活动类别 √特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 参与单位 中信建投证券、Anatole Investment Management Limited、dawn capital、 Dymon Asia Capital (HK) Limited、HBM Partners Hong Kong Limited、 KHAZANAH NASIONAL BERHAD、Manulife Investment Management (Hong Kong) Limited、开域资本（新加坡）有限公司、Pinpoint Asset Management Limited、Polymer Capital Management (HK) Limited、Ponit72、SCHP Management Limited、Strategic Vision Investment Limited、三井住友 德思资产管理株式会社、Tairen Capital Limited、Wil ...